Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating Activities
Net loss	$ (245,548)	$ (440,479)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	39,399	16,237
Deferred loan cost amortization	3,021	1,496
Equity-based compensation	38,189	332,759
Loss on extinguishment of debt	13,594	17,693
Paid in kind interest expense	5,118	0
Lease abandonment and impairment of long-lived assets	30,903	0
Changes in ROU asset	5,797	0
Other non-cash operating activities	0	1,783
Changes in operating assets and liabilities:
Accounts receivable	43,755	(137,509)
Inventories	(8,456)	(5,852)
Prepaid and other current assets	(2,844)	(6,205)
Accounts payable	(9,441)	(4,475)
Accrued liabilities	(8,559)	45,880
Due to related parties	0	(19,177)
Deferred revenue	26,416	5,834
Net cash used in operating activities	(68,656)	(192,015)
Investing Activities
Purchases of property, equipment, and intangible assets	(68,768)	(66,355)
Net cash used in investing activities	(68,768)	(66,355)
Financing Activities
Payment of IPO related costs	(1,155)
Proceeds from IPO		1,285,759
Proceeds from warrant exercise	922	0
Repurchase of Class A shares and related fees	0	(696,489)
Repurchase of Class A shares to cover employee tax withholdings	(6,976)	(81,603)
Settlement of canceled awards	0	(2,000)
Issuance of Class A common stock	0	6
Proceeds from HPS Credit Facility and Warrants, net	388,000	0
Borrowings on long-term debt	16,807	176,000
Payments of loan costs	(11,784)	(6,127)
Principal payments on long-term debt	(187,579)	(159,047)
Principal payments on related party debt	0	(24,581)
Payments on finance leases	(7,543)	0
Other	1,319	86
Net cash provided by financing activities	192,011	492,004
Increase in cash and cash equivalents	54,587	233,634
Cash and cash equivalents at beginning of period	318,458	313,929
Cash and cash equivalents at end of period	$ 373,045	$ 547,563